IPO : Glenmark Life Sciences Limited

Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies. Its products are being sold in India and also exported to multiple countries like Europe, North America, Latin America, Japan, etc. Currently, it has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of December 31, 2020.

The company has strong market share in select specialized APIs such as Telmisartan (anti-hypertensive), Atovaquone (anti-parasitic), Perindopril (antihypertensive), Teneligliptin (diabetes), Zonisamide (CNS) and Adapalene (dermatology). The company also increasingly provides contract development and manufacturing operations (CDMO) services to a range of multinational and specialty pharmaceutical companies. As of March 31, 2021, 16 of the 20 largest generic companies globally were its customers. The company intends to increase its API manufacturing capabilities at Ankleshwar facility during FY22, and Dahej facility during FY22 and FY23 by an aggregate annual total installed capacity of 200 KL. This additional production capacity is expected to help the company further expand generic API production and also grow oncology product pipeline.

Objectives of the Issue:

  • To make payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company.
  • To finance capital expenditure requirements.
  • To meet general corporate purposes.

SMART IPO using UPI , you can now apply online https://ipo.gwcindia.in/client/index.php

Further any clarification, feel free to contact your Branch / Relationship Manager.

For all your investment needs feel free to reach us. Give us a missed call at 90037 90027. For Support : 044-40329999

Warm Regards,
Team Goodwill

DISCLAIMER : Investments in the securities market are subject to market risk. Read all the related documents carefully before investing. The data and information herein provided are believed to be reliable, but Goodwill Wealth Management Pvt. Ltd., does not warrant its accuracy or completeness. Goodwill Wealth Management Pvt. Ltd., or any of its employees are not liable for any action taken by any party based on the above information. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Special note: Short-term trading on the basis of technical is high risk and skill-oriented venture and may result in huge losses also. Traders doing so are doing at their own risk. We are not responsible for any damages. Note: The material is being provided to you for educational purposes only and does not constitute investment advice; returns mentioned herein are in no way a guarantee or promise of future returns. See Disclaimer, Privacy Policy @ https://gwcindia.in/Disclaimer

 

Leave a reply:

Your email address will not be published.

Site Footer

© 2018 GOODWILL - ALL RIGHTS RESERVED